Details of the Target
General Information of Target
Target ID | LDTP02754 | |||||
---|---|---|---|---|---|---|
Target Name | D-amino-acid oxidase (DAO) | |||||
Gene Name | DAO | |||||
Gene ID | 1610 | |||||
Synonyms |
DAMOX; D-amino-acid oxidase; DAAO; DAMOX; DAO; EC 1.4.3.3 |
|||||
3D Structure | ||||||
Sequence |
MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPN
NPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPR ELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVN CTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGG IFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGP SNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL |
|||||
Target Type |
Clinical trial
|
|||||
Target Bioclass |
Enzyme
|
|||||
Family |
DAMOX/DASOX family
|
|||||
Subcellular location |
Peroxisome
|
|||||
Function |
Regulates the level of the neuromodulator D-serine in the brain. Has high activity towards D-DOPA and contributes to dopamine synthesis. Could act as a detoxifying agent which removes D-amino acids accumulated during aging. Acts on a variety of D-amino acids with a preference for those having small hydrophobic side chains followed by those bearing polar, aromatic, and basic groups. Does not act on acidic amino acids.
|
|||||
TTD ID | ||||||
Uniprot ID | ||||||
DrugMap ID | ||||||
Ensemble ID | ||||||
HGNC ID | ||||||
ChEMBL ID |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
ATP probe Probe Info |
![]() |
N.A. | LDD0035 | [1] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Enzyme
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
5'-AMP-activated protein kinase subunit beta-2 (PRKAB2) | 5'-AMP-activated protein kinase beta subunit family | O43741 |
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Benzoic Acid | Small molecular drug | DB03793 | |||
Flavin Adenine Dinucleotide | Small molecular drug | DB03147 |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Tak-831 | . | D03RXS |
Investigative
Discontinued
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Sep-227900 | . | D0XW4W |